Layoffs?

Discussion in 'AstraZeneca' started by anonymous, Jul 18, 2018 at 11:54 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Bull. Diabetes meds are paying the bills.
     

  2. anonymous

    anonymous Guest

    There is a hiring freeze and that’s never a good sign.
     
  3. anonymous

    anonymous Guest

    There has been a hiring freeze all year. The exceptions are onc, DSM's and very high priority territories
     
  4. anonymous

    anonymous Guest

    Try asking your fake CI vendor Sedulo Group. They can make up all the answers and clear this right up!
     
  5. anonymous

    anonymous Guest

    HR insider here....even Ray Charles, Stevie Wonder and Helen Keller can see that the field sales force is “overpopulated”. Layoffs in Q4. It is confirmed.
     
  6. anonymous

    anonymous Guest

    Did someone say Diabetes? Overpopulated, for sure!
     
  7. anonymous

    anonymous Guest

    Theres a greater chance of North Dakota becoming an island than AZ having layoffs. I've hoped for 5 years for a severance. Ain't gonna happen.
     
  8. anonymous

    anonymous Guest

    If you aren't in Oncology you are at risk. AZ has been structured into 2 companies; Oncology and "everything else". If you are in the "everything else" part of AZ you are at risk.
     
  9. anonymous

    anonymous Guest

    Tralokinumab was ineffective for asthma. Fasenra was ineffective in COPD. Now anifrolumab is ineffective in Lupus.

    Looks like oncology is the only viable place left.
     
  10. anonymous

    anonymous Guest

    Oh,wouldn't it be wonderful to finally get out with a severance package after all these years of waiting (2012). But, it's just not going to happen people. We will seriously be here until we resign with nothing or mess up and get fired. So,so many at least left with dignity the last couple of layoffs with a paycheck. AZ is going to just try to get people to leave. No severence packages or self identify EVER again. Bet on it.
     
  11. anonymous

    anonymous Guest

    AZ will never do self identify again without qualifiers. The ones who were within 3 years of retiring jumped at the chance the last time and left with significantly more money than if they had stayed. AZ paid them to do what they were going to do anyway and they laughed all the way to the bank. Ain't never going to happen again.
     
  12. anonymous

    anonymous Guest

    Not so fast my friend! Generic Advair will turn the respiratory market upside down. Initially it won’t affect primary care but it WILL affect hospitals. Hospitals that currently have Symbicort on formulary will drop it. The domino effect will begin and primary care customers will follow. The reps that have ridden the Medicaid wave will suffer because states will drop Symbicort and pick up generic Advair.

    It might take a year but AZ will have layoffs.
     
  13. anonymous

    anonymous Guest

    We don't get paid for Medicaid
     
  14. anonymous

    anonymous Guest

    and those hospitals that are DSH may still have a better price with Symbicort as well as 340B.
    Look back at history....Here's a couple. Crestor was a multi-billion dollar drug in a class that was 100% generic. Nexium grew to $6B when there was a generic Prilosec and Prevacid. It can be done.
     
  15. anonymous

    anonymous Guest

    Things were very different “back then” and there’s no head to head data like there was for Crestor!
     
  16. anonymous

    anonymous Guest

    Ye' of little faith.
     
  17. anonymous

    anonymous Guest

    That’s because you’re a jackwagon...